NDC 63323-965-01 - Potassium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-965
- Requested NDC
- 63323-965-01
- Package NDCs from labels
- 63323-965-01, 63323-965-05, 63323-965-03, 63323-965-10, 63323-965-02, 63323-965-20
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2025-08-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE, USP | Henry Schein, Inc. | 2025-08-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Potassium Chloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-02-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Potassium Chloride - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-29 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - General Injectables & Vaccines, Inc. | General Injectables & Vaccines, Inc. | 2022-12-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-965-01 | Potassium Chloride | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 5 | 5 | |
| 63323-965-02 | Potassium Chloride | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 20 | 5 | |
| 63323-965-03 | Potassium Chloride | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 10 | 5 | |
| 63323-965-05 | Potassium Chloride | 25 in 1 TRAY | INJECTION, SOLUTION, CONCENTRATE | 25 | 5 | |
| 63323-965-10 | Potassium Chloride | 25 in 1 TRAY | INJECTION, SOLUTION, CONCENTRATE | 25 | 5 | |
| 63323-965-20 | Potassium Chloride | 25 in 1 TRAY | INJECTION, SOLUTION, CONCENTRATE | 25 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-965-01 | ML - Milliliter | 63323-965 | 1bbfa031-5c7d-4660-bfc1-4d4f0c7b4049 | 1 | 2019-10-07 |
| 63323-965-02 | ML - Milliliter | 63323-965 | eb59be88-d60b-48d6-ae5b-4790007c02c5 | 1 | 2019-09-05 |
| 63323-965-03 | ML - Milliliter | 63323-965 | f645fe1e-bd3d-4cdc-99db-7744f42ecbab | 1 | 2019-10-07 |
| 63323-965-05 | ML - Milliliter | 63323-965 | 1908bab0-016a-48b3-93bc-249396e92c07 | 1 | 2012-07-24 |
| 63323-965-10 | ML - Milliliter | 63323-965 | 8be2fd64-e5a7-4231-b851-2399e724fac7 | 1 | 2012-07-24 |
| 63323-965-20 | ML - Milliliter | 63323-965 | 346766e4-da06-4c17-94c3-4ef8fe05b96e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Adare Pharmaceuticals Inc | 22edb0e6-4e45-4e91-aead-3581cca293a0 | 2023-12-20 | Warnings, Adverse reactions | 660YQ98I10 |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 28488c7b-cf6a-4a03-916f-cc66b3afdc57 | 2023-12-14 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 5aa0adf8-7b84-4cb0-be31-5c3333a6cc44 | 2023-12-11 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 5c4b0be5-625e-435f-9d2c-9d8fb407a8ea | 2023-12-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | d033c3b3-3ed6-4f23-a555-bae40cf0c48f | 2023-12-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Eye Wash | WATER | Jiangxi Zhenmei Biological Technology Co.,Ltd | c68795b8-bf68-0d01-e053-2a95a90abebb | 2023-12-04 | Warnings | 059QF0KO0R |
| Renotox | TRITICUM AESTIVUM, ASPARAGUS OFFICINALIS, BERBERIS VULGARIS, ECHINACEA (ANGUSTIFOLIA), KALI MURIATICUM, PETROSELINUM SATIVUM, SABAL SERRULATA, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, UVA-URSI, BAROSMA (BETULINA), EUPATORIUM PURPUREUM, KIDNEY (SUIS), BRYONIA (ALBA), MERCURIUS CORROSIVUS, ALUMINUM METALLICUM, ANTIMONIUM CRUDUM, ARGENTUM METALLICUM, ARSENICUM ALBUM, AURUM METALLICUM, BARYTA CARBONICA, BERYLLIUM METALLICUM, BISMUTHUM METALLICUM, BORON, BROMIUM, CADMIUM METALLICUM, CERIUM METALLICUM, | BioActive Nutritional, Inc. | b501f7bc-fa3a-494e-bf95-6779a3169a49 | 2023-11-17 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Sun Pharmaceutical Industries, Inc. | 0a1f2f64-3b0b-5e5c-e063-6294a90a7185 | 2023-11-14 | Warnings, Adverse reactions | 660YQ98I10 |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643994f-4e13-4572-e053-2991aa0a5b78 | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 6907bbfe-caa5-2ce4-e053-2991aa0ade8d | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643c518-13b2-658a-e053-2a91aa0ac5ed | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643e30e-1f47-09f1-e053-2991aa0ac2de | 2023-11-14 | QTT17582CB | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 86093c75-6de0-bb16-e053-2991aa0ab6ef | 2023-11-13 | 660YQ98I10 | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 86090ebb-0fb2-2c9c-e053-2a91aa0a0561 | 2023-11-13 | 660YQ98I10 | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 8608a8de-8133-1d4b-e053-2991aa0a907a | 2023-11-13 | 660YQ98I10 | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 860887e7-7eaf-78c2-e053-2991aa0a9a75 | 2023-11-13 | 660YQ98I10 | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 86086aab-c411-7cf2-e053-2991aa0a81bd | 2023-11-13 | 660YQ98I10 | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 8608a379-c3b7-3053-e053-2a91aa0a2e65 | 2023-11-13 | 660YQ98I10 | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 8608f3dd-31bf-0182-e053-2991aa0a1030 | 2023-11-13 | 660YQ98I10 | |
| Potassium Chloride | POTASSIUM CHLORIDE | Lupin Pharmaceuticals, Inc. | 1f33bcfe-c28a-4800-9241-685d974a5d91 | 2023-11-08 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.